Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy
- PMID: 17699387
- DOI: 10.2215/CJN.02670706
Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy
Abstract
Acute renal failure that is associated with macroscopic hematuria (ARF-MH) is a widely known complication of IgA nephropathy (IgAN). Although spontaneous recovery of renal function after cessation of MH has been described, no long-term outcome studies have been performed. The outcome of patients who had biopsy-proven IgAN and presented an ARF-MH episode in the period 1975 through 2005 was studied. Thirty-six episodes of ARF-MH that occurred in 32 patients were identified. A complete recovery of baseline renal function after cessation of MH was observed in 27 (group 1); in the remaining nine episodes (25%; group 2), estimated GFR (eGFR) did not reach the baseline value. Final eGFR was 89 +/- 28 ml/min per 1.73 m(2) in group 1 patients and 38 +/- 12 ml/min per 1.73 m(2) in group 2 patients (P = 0.0005). The duration of MH was significantly longer in group 2 patients: 33.7 +/- 25.3 versus 15.4 +/- 18.4 d (P = 0008). A high proportion of tubules that were filled by red blood cell casts and had signs of acute tubular necrosis were the most striking histologic abnormalities. In conclusion, a significant proportion (25%) of ARF-MH in IgAN did not recover the baseline renal function after the disappearance of MH. Duration of MH longer than 10 d, age >50 yr, decreased baseline eGFR, absence of previous episodes of MH, and the severity of tubular necrosis were significant risk factors for an incomplete recovery of renal function.
Similar articles
-
Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury.Ther Apher Dial. 2009 Aug;13(4):273-7. doi: 10.1111/j.1744-9987.2009.00723.x. Ther Apher Dial. 2009. PMID: 19695058
-
The spectrum of acute renal failure in IgA nephropathy.Ren Fail. 2010 May;32(4):428-33. doi: 10.3109/08860221003646345. Ren Fail. 2010. PMID: 20446779
-
Acute reversible renal failure with macroscopic haematuria in IgA nephropathy.Nephrol Dial Transplant. 1993;8(3):195-9. Nephrol Dial Transplant. 1993. PMID: 8385283
-
Factors predicting progression of IgA nephropathies.J Nephrol. 2005 Sep-Oct;18(5):503-12. J Nephrol. 2005. PMID: 16299675 Review.
-
Pediatric IgA nephropathy: clinical and therapeutic perspectives.Semin Nephrol. 2008 Jan;28(1):18-26. doi: 10.1016/j.semnephrol.2007.10.003. Semin Nephrol. 2008. PMID: 18222343 Review.
Cited by
-
Role of Iron in Children With Immunoglobulin A Nephropathy and Macrohematuria-Induced Acute Kidney Injury.Kidney Int Rep. 2024 Mar 9;9(6):1664-1673. doi: 10.1016/j.ekir.2024.03.003. eCollection 2024 Jun. Kidney Int Rep. 2024. PMID: 38899207 Free PMC article.
-
IgA nephropathy.Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9. Nat Rev Dis Primers. 2023. PMID: 38036542 Review.
-
Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy.Kidney Int Rep. 2023 Jun 5;8(8):1596-1604. doi: 10.1016/j.ekir.2023.05.027. eCollection 2023 Aug. Kidney Int Rep. 2023. PMID: 37547537 Free PMC article.
-
The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis.Front Immunol. 2023 Jul 3;14:1192941. doi: 10.3389/fimmu.2023.1192941. eCollection 2023. Front Immunol. 2023. PMID: 37529043 Free PMC article. Review.
-
IgA Nephropathy: Current Treatment and New Insights.Antibodies (Basel). 2023 Jun 19;12(2):40. doi: 10.3390/antib12020040. Antibodies (Basel). 2023. PMID: 37366657 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
